February 11, 2011 – The drug maker Bristol-Myers Squibb recently issued a recall for its blood pressure drug Avalide, which generated revenues of $310 million between January and September 2010,...
Blood Disorder Drug Revlimid May Increase Risk of Cancer Development
April 26, 2011 – Patients treated with Revlimid may be at an increased risk of developing new types of cancer according to recent clinical trials. The U.S. Food and Drug Administration (FDA) has obtained...
Warnings for Multiple Sclerosis Drug Tysabri Updated by FDA
April 25, 2011 – The Food and Drug Administration has announced additional warnings to be included on the labels and literature regarding the popular drug Tysabri. On April 22nd, the FDA posted new updates to the...